{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:30Z","timestamp":1790697990356,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11307-015-0839-3","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T15:44:18Z","timestamp":1426779858000},"page":"726-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Influence of Early Measurements Onto the Estimated Kidney Dose in [177Lu][DOTA0,Tyr3]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors"],"prefix":"10.1007","volume":"17","author":[{"given":"Andreas","family":"Delker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Zach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Josef","family":"Gildehaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"B\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"839_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","volume":"95","author":"M Pavel","year":"2012","unstructured":"Pavel M, Baudin E, Couvelard A et al (2012) ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95:157\u2013176","journal-title":"Neuroendocrinology"},{"key":"839_CR2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","volume":"40","author":"L Bodei","year":"2013","unstructured":"Bodei L, Mueller-Brand J, Baum RP et al (2013) The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 40:800\u2013816","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"839_CR3","doi-asserted-by":"crossref","unstructured":"van der Zwan WA, Bodei L, Mueller-Brand J, et al. (2014) GEP-NETS update: radionuclide therapy in neuroendocrine tumors. European journal of endocrinology \/ European Federation of Endocrine Societies","DOI":"10.1530\/EJE-14-0488"},{"key":"839_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2014.00009","volume":"13","author":"W Koch","year":"2014","unstructured":"Koch W, Auernhammer CJ, Geisler J et al (2014) Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography. Mol Imaging 13:1\u201310","journal-title":"Mol Imaging"},{"issue":"Suppl 1","key":"839_CR5","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/s00259-011-2002-y","volume":"39","author":"L Bodei","year":"2012","unstructured":"Bodei L, Cremonesi M, Grana CM et al (2012) Yttrium-labelled peptides for therapy of NET. Eur J Nucl Med Mol Imaging 39(Suppl 1):S93\u2013S102","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"839_CR6","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s00259-011-2039-y","volume":"39","author":"BL Kam","year":"2012","unstructured":"Kam BL, Teunissen JJ, Krenning EP et al (2012) Lutetium-labelled peptides for therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging 39(Suppl 1):S103\u2013S112","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"839_CR7","first-page":"134","volume":"48","author":"M Konijnenberg","year":"2007","unstructured":"Konijnenberg M, Melis M, Valkema R et al (2007) Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy. J Nuclear Med : Off Public Soc Nuclear Med 48:134\u2013142","journal-title":"J Nuclear Med : Off Public Soc Nuclear Med"},{"key":"839_CR8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109\u2013122","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"839_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/2191-219X-2-49","volume":"2","author":"M Larsson","year":"2012","unstructured":"Larsson M, Bernhardt P, Svensson JB et al (2012) Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy. EJNMMI Res 2:49","journal-title":"EJNMMI Res"},{"key":"839_CR10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00259-003-1142-0","volume":"30","author":"WA Breeman","year":"2003","unstructured":"Breeman WA, De Jong M, Visser TJ et al (2003) Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities. Eur J Nucl Med Mol Imaging 30:917\u2013920","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"839_CR11","first-page":"2216","volume":"34","author":"T Ichihara","year":"1993","unstructured":"Ichihara T, Ogawa K, Motomura N et al (1993) Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nuclear Med : Off Public Soc Nuclear Med 34:2216\u20132221","journal-title":"J Nuclear Med : Off Public Soc Nuclear Med"},{"key":"839_CR12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1088\/0031-9155\/24\/1\/017","volume":"24","author":"JS Fleming","year":"1979","unstructured":"Fleming JS (1979) A technique for the absolute measurement of activity using a gamma camera and computer. Phys Med Biol 24:176\u2013180","journal-title":"Phys Med Biol"},{"key":"839_CR13","first-page":"37S","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB et al (1999) MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nuclear Med : Off Public Soc Nuclear Med 40:37S\u201361S","journal-title":"J Nuclear Med : Off Public Soc Nuclear Med"},{"key":"839_CR14","volume-title":"XCOM: photon cross section database (version 1.5). http:\/\/physics.nist.gov\/xcom","author":"MJ Berger","year":"2010","unstructured":"Berger MJ, Hubbell JH, Seltzer SM (2010) XCOM: photon cross section database (version 1.5). http:\/\/physics.nist.gov\/xcom . National Institute of Standards and Technology, Gaithersburg"},{"key":"839_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1118\/1.597057","volume":"20","author":"A Kojima","year":"1993","unstructured":"Kojima A, Takaki Y, Matsumoto M et al (1993) A preliminary phantom study on a proposed model for quantification of renal planar scintigraphy. Med Phys 20:33\u201337","journal-title":"Med Phys"},{"key":"839_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1088\/0031-9155\/13\/2\/306","volume":"13","author":"R Loevinger","year":"1968","unstructured":"Loevinger R, Berman M (1968) A formalism for calculation of absorbed dose from radionuclides. Phys Med Biol 13:205\u2013217","journal-title":"Phys Med Biol"},{"key":"839_CR17","unstructured":"Stabin M, Siegel J, Hunt J et al (2001) RADAR: the radiation dose assessment resource. J Nucl Med 42"},{"key":"839_CR18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cncr.10290","volume":"94","author":"LE Williams","year":"2002","unstructured":"Williams LE, Liu A, Yamauchi DM et al (2002) The two types of correction of absorbed dose estimates for internal emitters. Cancer 94:1231\u20131234","journal-title":"Cancer"},{"key":"839_CR19","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2967\/jnumed.112.106138","volume":"53","author":"MG Stabin","year":"2012","unstructured":"Stabin MG, Xu XG, Emmons MA et al (2012) RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry. J Nuclear Med : Off Public Soc Nuclear Med 53:1807\u20131813","journal-title":"J Nuclear Med : Off Public Soc Nuclear Med"},{"key":"839_CR20","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1118\/1.2794176","volume":"34","author":"G Glatting","year":"2007","unstructured":"Glatting G, Kletting P, Reske SN et al (2007) Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. Med Phys 34:4285\u20134292","journal-title":"Med Phys"},{"key":"839_CR21","doi-asserted-by":"crossref","first-page":"102504","DOI":"10.1118\/1.4820367","volume":"40","author":"P Kletting","year":"2013","unstructured":"Kletting P, Schimmel S, Kestler HA et al (2013) Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient. Med Phys 40:102504","journal-title":"Med Phys"},{"key":"839_CR22","doi-asserted-by":"crossref","first-page":"N501","DOI":"10.1088\/0031-9155\/54\/21\/N01","volume":"54","author":"P Kletting","year":"2009","unstructured":"Kletting P, Kull T, Reske SN, Glatting G (2009) Comparing time activity curves using the Akaike information criterion. Phys Med Biol 54:N501\u2013N507","journal-title":"Phys Med Biol"},{"key":"839_CR23","doi-asserted-by":"crossref","first-page":"935351","DOI":"10.1155\/2013\/935351","volume":"2013","author":"F Guerriero","year":"2013","unstructured":"Guerriero F, Ferrari ME, Botta F et al (2013) Kidney dosimetry in (1)(7)(7)Lu and (9)(0)Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors. BioMed Res Int 2013:935351","journal-title":"BioMed Res Int"},{"key":"839_CR24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1118\/1.2836421","volume":"35","author":"S Baechler","year":"2008","unstructured":"Baechler S, Hobbs RF, Prideaux AR et al (2008) Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry. Med Phys 35:1123\u20131134","journal-title":"Med Phys"},{"key":"839_CR25","first-page":"37","volume":"54","author":"M Cremonesi","year":"2010","unstructured":"Cremonesi M, Botta F, Di Dia A et al (2010) Dosimetry for treatment with radiolabelled somatostatin analogues. a review. Quart J Nuclear Med Molec Imag : Off Public Italian Assoc Nuclear Med 54:37\u201351","journal-title":"Quart J Nuclear Med Molec Imag : Off Public Italian Assoc Nuclear Med"},{"key":"839_CR26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cncr.24796","volume":"116","author":"M Garkavij","year":"2010","unstructured":"Garkavij M, Nickel M, Sjogreen-Gleisner K et al (2010) 177Lu-[DOTA0, Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy. Cancer 116:1084\u20131092","journal-title":"Cancer"},{"key":"839_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00259-009-1216-8","volume":"37","author":"M Sandstrom","year":"2010","unstructured":"Sandstrom M, Garske U, Granberg D et al (2010) Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate. Eur J Nucl Med Mol Imaging 37:212\u2013225","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"839_CR28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1102\/1470-7330.2011.0012","volume":"11","author":"JM Beauregard","year":"2011","unstructured":"Beauregard JM, Hofman MS, Pereira JM et al (2011) Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT\/CT system. Cancer Imag : official Public Int Cancer Imag Soc 11:56\u201366","journal-title":"Cancer Imag : official Public Int Cancer Imag Soc"},{"key":"839_CR29","doi-asserted-by":"crossref","unstructured":"Sanders JC, Kuwert T, Hornegger J, Ritt P (2014) Quantitative SPECT\/CT Imaging of Lu with in vivo validation in patients undergoing peptide receptor radionuclide therapy. Molec Imag Biol: MIB : Off Public Acad Molec Imag","DOI":"10.1007\/s11307-014-0806-4"},{"key":"839_CR30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s002590100574","volume":"28","author":"DJ Kwekkeboom","year":"2001","unstructured":"Kwekkeboom DJ, Bakker WH, Kooij PP et al (2001) [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients. Eur J Nucl Med 28:1319\u20131325","journal-title":"Eur J Nucl Med"},{"key":"839_CR31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/cbr.2006.325","volume":"22","author":"C Wehrmann","year":"2007","unstructured":"Wehrmann C, Senftleben S, Zachert C et al (2007) Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC. Cancer Biother Radiopharm 22:406\u2013416","journal-title":"Cancer Biother Radiopharm"},{"key":"839_CR32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00259-004-1561-6","volume":"31","author":"A Helisch","year":"2004","unstructured":"Helisch A, Forster GJ, Reber H et al (2004) Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol Imaging 31:1386\u20131392","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"839_CR33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-10-6","volume":"10","author":"AN Spiess","year":"2010","unstructured":"Spiess AN, Neumeyer N (2010) An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach. BMC Pharmacol 10:6","journal-title":"BMC Pharmacol"},{"key":"839_CR34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00259-010-1549-3","volume":"38","author":"M Lassmann","year":"2011","unstructured":"Lassmann M, Chiesa C, Flux G et al (2011) EANM dosimetry committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging 38:192\u2013200","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-015-0839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-015-0839-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-015-0839-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T04:47:31Z","timestamp":1566449251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-015-0839-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s11307-015-0839-3","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}